Express Scripts Holding Co

Find Ratings Reports
ESRX : NASDAQ : Health Care
$61.88 up 0.16 | 0.26%
Today's Range: 61.39 - 61.925
Avg. Daily Volume: 3075100.0
09/22/17 - 12:01 PM ET

Financial Analysis


EXPRESS SCRIPTS HOLDING CO's gross profit margin for the second quarter of its fiscal year 2017 is essentially unchanged when compared to the same period a year ago. The company has grown sales and net income during the past quarter when compared with the same quarter a year ago, however, it was unable to keep up with the growth of the average competitor within its industry. EXPRESS SCRIPTS HOLDING CO has weak liquidity. Currently, the Quick Ratio is 0.56 which shows a lack of ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.

At the same time, stockholders' equity ("net worth") has remained virtually unchanged only increasing by 2.21% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)25347.525222.3
EBITDA ($mil)1772.41749.1
EBIT ($mil)1378.61256.3
Net Income ($mil)801.8720.7


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)2352.51324.4
Total Assets ($mil)50513.450858.6
Total Debt ($mil)14986.515983.5
Equity ($mil)15744.615403.1


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin8.658.68
EBITDA Margin6.996.93
Operating Margin5.444.98
Sales Turnover1.991.99
Return on Assets6.945.27
Return on Equity22.2617.41
Debt Q2 FY17 Q2 FY16
Current Ratio0.690.55
Debt/Capital0.490.51
Interest Expense146.5136.8
Interest Coverage9.419.18


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)577.55630.22
Div / share0.00.0
EPS1.371.13
Book value / share27.2624.44
Institutional Own % n/a n/a
Avg Daily Volume3232034.04885784.0

Valuation


HOLD. EXPRESS SCRIPTS HOLDING CO's P/E ratio indicates a significant discount compared to an average of 23.80 for the Health Care Providers & Services industry and a significant discount compared to the S&P 500 average of 24.88. For additional comparison, its price-to-book ratio of 2.29 indicates a discount versus the S&P 500 average of 3.10 and a discount versus the industry average of 3.33. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount. Upon assessment of these and other key valuation criteria, EXPRESS SCRIPTS HOLDING CO proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ESRX 10.82 Peers 23.80   ESRX 6.34 Peers 11.90

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ESRX is trading at a significant discount to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ESRX 8.17 Peers 16.92   ESRX 0.36 Peers 0.71

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ESRX is trading at a significant discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ESRX trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ESRX 2.29 Peers 3.33   ESRX 42.57 Peers 20.55

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ESRX is trading at a significant discount to its peers.

 

Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ESRX is expected to have an earnings growth rate that significantly exceeds its peers.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ESRX 0.36 Peers 0.92   ESRX -1.13 Peers 8.42

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ESRX is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ESRX significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades